Global human identification market is projected to experience rapid growth, reaching a value of US$3.9 billion by 2032

The global human identification market estimated at US$1.42 billion in the year 2025 is projected to grow at a CAGR of 15.6% and reach US$3.91 billion by 2032, primarily driven by increasing demand for forensic and criminal investigation applications worldwide. Law enforcement agencies are adopting advanced DNA profiling, fingerprint analysis, and biometric identification technologies to improve the accuracy and speed of suspect identification, missing-person investigations, disaster victim identification, and criminal case resolution. Rising crime rates, growing cross-border security concerns, and the expansion of national biometric databases are encouraging governments to invest in next-generation human identification solutions. In addition, technological advancements in genetic analysis, automated fingerprint identification systems (AFIS), and digital forensic platforms are enhancing operational efficiency and expanding the use of human identification technologies across public safety agencies.

Another major growth driver is the increasing application of human identification technologies in healthcare, clinical research, and ancestry testing. The growing adoption of genomic sequencing, personalized medicine, organ transplantation matching, and hereditary disease screening has increased demand for accurate human identification and genetic verification tools. Pharmaceutical and biotechnology companies are utilizing DNA-based identification methods in clinical trials, biobanking, and precision medicine initiatives to ensure sample integrity and patient traceability. Furthermore, expanding consumer interest in genealogy and direct-to-consumer genetic testing services is contributing to market growth, particularly in developed economies.

Looking ahead, the market presents significant growth opportunities through the integration of artificial intelligence, next-generation sequencing (NGS), and cloud-based forensic data management platforms. Emerging economies are expected to witness increased adoption of biometric and DNA identification systems as governments strengthen national security frameworks and modernize forensic laboratories. The growing use of rapid DNA testing at crime scenes, border control checkpoints, disaster response operations, and military applications is expected to create new revenue streams for market participants. Additionally, advancements in portable identification devices, multi-modal biometrics, and large-scale genomic databases are likely to expand the scope of human identification technologies, supporting sustained market growth over the coming decade.

Strong growth curves for the emerging markets

The North American human identification market is expected to grow significantly during the forecast period. The regional market growth is propelled by strong investments in forensic science, widespread adoption of DNA analysis and biometric technologies, increasing criminal investigation activities, expanding genomic research, and growing demand for precision medicine and public security solutions. United States contributed around 81% of the total North American human identification market is estimated to have a market value of US$388.5 million in the year 2025. Among the other noteworthy geographic markets are Canada and Mexico, each forecast to grow at 12.31% and 10.46% respectively over the 2025-2032 period.

The Asia-Pacific human identification market is experiencing rapid growth, fueled by expanding national identification programs, increasing adoption of DNA profiling in forensic investigations, growing investments in healthcare and genetic testing, and rising border security requirements across developing economies. China is expected to dominate the Asia-Pacific market and reach a market size of US$436.1 million by 2032.

The European human identification market is driven by increasing forensic DNA database expansion in the UK, Germany, and France, growing biometric border-control initiatives across the European Union, rising genomic research investments in Germany and the Nordic countries, and strengthened law enforcement collaboration for cross-border crime prevention and identification. Germany is expected to grow at a CAGR of 14.19% over the forecast period.

Meanwhile, the Middle East & Africa is expected to show limited growth due to the strong presence of under-developed countries in Africa who are still struggling to meet technology standards. However, any growth that the region experiences is expected to come from developing Middle Eastern nations such as Qatar, U.A.E, and Oman due to a similar growth pattern as the Asia Pacific.

Key players profiled in the report include Agilent Technologies; Bioneer Corporation; Bio-Rad Laboratories, Inc.; Danaher Corporation; Eurofins Scientific SE; GE Healthcare; Hamilton Company; Illumina, Inc.; Innogenomics Technologies LLC; IntegenX, Inc.; Laboratory Corporation of America Holdings (LabCorp); LGC Ltd.; Promega Corporation; Qiagen NV; Thermo Fisher Scientific, Inc. and Waters Corporation, among others.

Competitive Landscape

QIAGEN expanded its Human ID and forensic genomics strategy in 2026, highlighting continued growth of its QIAcuity digital PCR platform, which surpassed 3,200 cumulative placements globally by the end of 2025. The company also announced new assay offerings and increased investment in AI-enabled bioinformatics and genomic analysis solutions.

MGI Tech showcased advanced laboratory automation and multi-omics solutions at SLAS Europe 2026, highlighting integrated sequencing and automated sample-processing workflows that can support next-generation human identification, forensic genomics, and precision medicine applications.

TABLE OF CONTENTS

1. Research methodology
   1. Primary research
   2. Secondary research
   3. Market analytics
   4. Revenue forecasting
2. Executive summary
3. Market overview
   1. Introduction to human identification
   2. Technology analysis
      1. Key underlying technologies
      2. Enabling / Complementary digital technologies
      3. Emerging technologies
   3. Market dynamics
      1. Market trends & drivers
      2. Challenges hindering market growth
      3. Future outlook & opportunities
   4. Porter’s five forces analysis
   5. Supply chain & ecosystem
   6. Pricing analysis
   7. Global economic, geopolitical and industry outlook
      1. Global macroeconomic outlook
      2. Geopolitical risk analysis
   8. Regulatory framework, standards and tariff analysis
4. Global Market Outlook
   1. Breakdown by component
      1. Consumables
      2. Instruments
      3. Software
   2. Breakdown by technology
      1. PCR
      2. Capillary electrophoresis
      3. Next-generation sequencing (NGS)
      4. Microarray
      5. Rapid DNA analysis
   3. Breakdown by end-use
      1. Forensic laboratories
      2. Government & law enforcement agencies
      3. Research centers & academic institutes
      4. Others
5. Regional Market Outlook
   1. United States
   2. Canada
   3. Europe
      1. France
      2. Germany
      3. Italy
      4. UK
      5. Spain
      6. Russia
      7. Rest of Europe
   4. Asia-Pacific
      1. China
      2. Japan
      3. Australia
      4. India
      5. South Korea
      6. Rest of Asia-Pacific
   5. Latin America
      1. Argentina
      2. Brazil
      3. Mexico
      4. Rest of Latin America
   6. Middle East
      1. Iran
      2. Israel
      3. Saudi Arabia
      4. UAE
      5. Rest of Middle East
   7. Africa
6. Competitive Landscape
   1. Overview of global competition
   2. Company positioning & benchmarking
   3. Strategic competitive approaches
7. Company profiles

Abbott Laboratories

Agilent Technologies

Ande Corporation

AutoGen, Inc.

Bioneer Corporation

Bio-Rad Laboratories, Inc.

BIOTYPE GmbH

Bode Cellmark Forensics Inc.

Carolina Biological Supply Company

Complete Genomics Incorporated

Cybergenetics Inc

Cytiva

Danaher Corporation

Element Biosciences

Eurofins Scientific SE

Fujifilm Wako Pure Chemical Corporation

GE Healthcare

Genetek Biopharma GmbH

Genex Diagnostics Inc.

Geno Technology Inc.

Hamilton Company

Hitachi Ltd.

Illumina, Inc.

Innogenomics Technologies LLC

IntegenX, Inc.

Laboratory Corporation of America Holdings (LabCorp)

LGC Limited

MACHEREY-NAGEL GmbH & Co. KG

Merck KGaA

Mgi Tech Co. Ltd.

Ningbo Health Gene Technologies Co. Ltd.

Othram

Oxford Nanopore Technologies (ONT)

PerkinElmer Inc.

Promega Corporation

Qiagen NV

Siemens Healthineers AG

Singular Genomics Systems, Inc.

Softgenetics

Sorenson Forensics

Strmix Limited

Tecan Trading AG

Thermo Fisher Scientific, Inc.

Ultima Genomics, Inc.

Versaterm

Watchmaker Genomics

Waters Corporation

Zeiss